Edition:
United States

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

13.09USD
4:00pm EDT
Change (% chg)

$-0.81 (-5.83%)
Prev Close
$13.90
Open
$13.95
Day's High
$14.19
Day's Low
$12.55
Volume
36,854
Avg. Vol
24,156
52-wk High
$94.80
52-wk Low
$4.27

Chart for

About

Altimmune, Inc., formerly Pharmathene, Inc., is a clinical-stage immunotherapeutic company. The Company focuses in development of medical counter measures against biological and chemical threats. The Company is involved in development of two next generation anthrax vaccines. It has two proprietary platform technologies,... (more)

Overall

Beta: 2.56
Market Cap(Mil.): $17.83
Shares Outstanding(Mil.): 1.28
Dividend: 873.00
Yield (%): --

Financials

  ALT.OQ Industry Sector
P/E (TTM): -- 109.17 32.55
EPS (TTM): -98.65 -- --
ROI: -76.60 1.47 12.80
ROE: -102.48 0.22 14.92

BRIEF-Altimmune Q1 Loss Per Share $0.25

* ALTIMMUNE ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 15 2018

BRIEF-Altimmune Says Elizabeth Czerepak Resigned From Her Position As Chief Financial Officer

* ALTIMMUNE INC - ON MAY 8 ELIZABETH CZEREPAK RESIGNED FROM HER POSITION AS CHIEF FINANCIAL OFFICER

May 10 2018

BRIEF-Altimmune Announces Positive Data From Its Phase 2A Study Of Nasovax Intranasal Influenza Vaccine

* ALTIMMUNE ANNOUNCES POSITIVE DATA FROM ITS PHASE 2A STUDY OF NASOVAX INTRANASAL INFLUENZA VACCINE AND PROVIDES AN UPDATE ON ITS PHASE 1B STUDY OF HEPTCELL TARGETED IMMUNOTHERAPY IN CHRONIC HEPATITIS B INFECTION

Mar 27 2018

Competitors

  Price Chg
Green Cross Corp (006280.KS) ₩202,000.00 0.00
Pfizer Inc. (PFE.N) $43.79 -0.14
Panacea Biotec Limited (PNCA.NS) Rs190.85 -3.35
Bavarian Nordic A/S (BAVA.CO) kr.176.40 +0.25
Emergent Biosolutions Inc (EBS.N) $66.51 +0.06
Ibio Inc (IBIO.A) $0.89 -0.01
Soligenix Inc (SNGX.OQ) $1.62 +0.07
Pfenex Inc (PFNX.A) $5.10 +0.13

Earnings vs. Estimates